Concepedia

Publication | Closed Access

Efficacy and Safety of Semaglutide Once-Weekly vs. Placebo as Add-on to Basal Insulin Alone or in Combination with Metformin in Subjects with Type 2 Diabetes (SUSTAIN 5)

25

Citations

0

References

2016

Year

No additional data available for this publication yet. Check back later!